Anthem Biosciences

Anthem Biosciences

Integrated preclinical development services and platform technologies for tox testing and cell line engineering

Founded

2006

Headquarters

Bengaluru (India)

Status

Series C

Company Details

Website

Socials

Email

Phone

+91-8040444000

Anthem Biosciences is a prominent Contract Research and Innovation Service Provider (CRISP) based in Bangalore, India. Established in 2007, the company has rapidly evolved into a key player in drug development and research services, offering a wide range of capabilities to pharmaceutical, biotechnology, and specialty chemicals industries.

Services Offered

Anthem Biosciences provides comprehensive services across various domains:

  1. Chemistry Services:

    • Medicinal Chemistry

    • Library Design and Synthesis

    • Process Development and Custom Synthesis

    • GMP Manufacturing from milligram to kilogram scale

  2. Biology Services:
    • Molecular Biology

    • DMPK (Drug Metabolism and Pharmacokinetics)

    • Microbiology and Pharmacology

    • Preclinical services with GLP & AAALAC accreditation

  3. Integrated Drug Discovery:
    • Offers end-to-end services from concept to IND (Investigational New Drug) filing, allowing clients to streamline their research processes.

  4. Platform Technologies:
    • Development of patented tools for preclinical drug discovery, including diagnostic assays for toxicity testing.

  5. Anthem Cellutions:
    • The product arm focused on nutraceuticals and dietary supplements, providing innovative products supported by scientific studies.

  6. Anthem Biopharma:
    • A division dedicated to branded formulations in diabetology and nephrology, focusing on safe and extensively tested products.

Business Model

Anthem Biosciences operates on various business models such as FTE (Full-Time Equivalent) and FFS (Fee for Service), allowing flexibility to meet client needs based on project complexity.

Accreditations and Compliance

The company adheres to stringent regulatory standards, ensuring high-quality service delivery. Their facilities are designed to comply with cGMP regulations, and they maintain robust EHS (Environmental Health and Safety) policies.

Recent Developments

Anthem has recently expanded its laboratory space, doubling its capacity with new facilities for in-vivo studies, ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) testing, and fermentation processes.

Conclusion

Anthem Biosciences stands out as a top-tier Contract Research Organization (CRO) due to its experienced team, comprehensive service offerings, and commitment to quality. The company continues to innovate in the drug discovery space while providing reliable support for clients across various sectors within the life sciences industry.

Key People

Ajay Bharadwaj

Ganesh Sambashivam

Gawir Baig

Ravindra K C

Key Metrics

Total Equity Funding

$35.7Million

No. of Funding Rounds

4

Latest Funding Round

$33.4Million, Series C

as of March 1, 2021

Post Money Valuation

$997Million

as of N/A

Funding Multiple

2.39

as of N/A

Investors

Portsmouthtechnologiestrialsunit

and 4 more

Employee Count

2070

Similar Companies

Vectura

Exit Details

-

All Funding Rounds

DateRound NameAmountValuationRevenueRevenue Multiple
Investors
March 1, 2021Series C$33.4Million$999.0Million$154.0Million6.1x True North ,Khaitan, o3 Capital, MD&T Partners
November 14, 2016Seed$1.7Million$30.9Billion$52.0Million607.7xCo Portsmouthtechnologiestrialsunit
May 29, 2008Seed$577.0K$12.0Million-- Portsmouthtechnologiestrialsunit

Recent News